id
int64 1
100k
| graph_name
stringclasses 1
value | schema
stringclasses 1
value | input
stringlengths 43
565
| output
stringlengths 122
887
|
---|---|---|---|---|
99,901 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Quadras Scientific Solutions in Hangzhou, Zhejiang, China involving Pulmonary Tuberculoses and BDP HFA Nasal Aerosol. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,902 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies conducted by Quadras Scientific Solutions involving Intervertebral Disc Disorder Lumbar With Radiculopathy and Placebo to SHP-141C in San Francisco. Who collaborated, and what were the outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Intervertebral Disc Disorder Lumbar With Radiculopathy'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,903 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies supported by J&J in Kristianstad, Sweden that investigated Thalassemia Intermedia and Recombinant new coronavirus vaccine (CHO cell) low-dose group. Include details of primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'J&J'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,904 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by INDIV in PHASE1 were conducted at Los Angeles and involved Ventricular Ectopic Beat(S) as well as Gelfoam? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,905 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by NIH in PHASE3 at Chicago. Include Ventricular Ectopic Beat(S), Recombinant new coronavirus vaccine (CHO cell) low-dose group, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,906 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE2 funded by FED at New York involving Ischemic Heart Disease (IHD) and diet and exercise. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ischemic Heart Disease (IHD)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,907 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies sponsored by Pfizer in Chicago that studied Intervertebral Disc Disorder Lumbar With Radiculopathy and Gelfoam. Include primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Pfizer'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Intervertebral Disc Disorder Lumbar With Radiculopathy'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,908 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | What studies were conducted by Pfizer in New York and involved Orthodontic Retainers as well as TQ-A3334? What were the primary and secondary outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Pfizer'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Orthodontic Retainers'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,909 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies funded by UNKNOWN in PHASE1 at Los Angeles involving Laryngeal Dystonia and Active MBM. Include details of outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,910 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Vancouver Prostate Centre in Chicago involving Human Flu and Amivantamab (to be determined). Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Amivantamab (to be determined)'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,911 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by AMBIG in PHASE1 at Kristianstad, Sweden that involved Ventricular Ectopic Beat(S) and 10 % lidocaine spray without adrenaline. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: '10 % lidocaine spray without adrenaline'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,912 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by UNKNOWN in PHASE2|PHASE3 at Lund, Sweden. Include Ketamine Treatment, delandistrogene moxeparvovec, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ketamine Treatment'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,913 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by OTHER_GOV in EARLY_PHASE1 at Helsingborg, Sweden. Include Post Cardiac Surgery, Mayo Clinic Foregut Surgery Report Card Questionnaire, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER_GOV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Mayo Clinic Foregut Surgery Report Card Questionnaire'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,914 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies conducted by NSABP Foundation Inc involving Chronic Antibody-mediated Transplant Rejection and TQ-A3334 in Boston. Who collaborated, and what were the outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,915 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Human Flu in PHASE3 funded by FED, involving BDP HFA Nasal Aerosol. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,916 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Quadras Scientific Solutions in Helsingborg, Sweden involving Recurrent Hypopharyngeal Squamous Cell Carcinoma and TQ-A3334. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,917 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies supported by J&J that involved Recurrent Hypopharyngeal Squamous Cell Carcinoma and relaxation response- meditation in Hangzhou, Zhejiang, China. Include collaborators and outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'J&J'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,918 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies supported by NSABP Foundation Inc in Los Angeles that investigated Alpha1-antitrypsin Deficiency and 10 % lidocaine spray without adrenaline. Include details of primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Alpha1-antitrypsin Deficiency'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: '10 % lidocaine spray without adrenaline'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,919 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by NIH in PHASE1|PHASE2 at Hangzhou, Zhejiang, China. Include Thalassemia Intermedia, Nalmefene (Selincro®) 18 mg tablet, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,920 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE3 funded by FED at San Francisco involving Laryngeal Dystonia and relaxation response- meditation. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,921 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by AMBIG in PHASE1|PHASE2 were conducted at San Francisco and involved Human Flu as well as diet and exercise? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,922 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Pfizer in Kristianstad, Sweden involving Laryngeal Dystonia and relaxation response- meditation. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Pfizer'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,923 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by OTHER_GOV in PHASE2 at Hangzhou, Zhejiang, China that involved Ventricular Ectopic Beat(S) and Gelfoam. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER_GOV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,924 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE1 funded by OTHER at Lund, Sweden involving Pulmonary Tuberculoses and diet and exercise. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,925 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by INDIV in EARLY_PHASE1 were conducted at San Francisco and involved Chorea Associated With Huntington Disease as well as Guided bone regeneration? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chorea Associated With Huntington Disease'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Guided bone regeneration'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,926 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies funded by INDIV in PHASE1|PHASE2 at Lund, Sweden involving Intervertebral Disc Disorder Lumbar With Radiculopathy and Recombinant new coronavirus vaccine (CHO cell) low-dose group. Include details of outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Intervertebral Disc Disorder Lumbar With Radiculopathy'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,927 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by NETWORK in PHASE4 at Chicago. Include Neurocognitive Dysfunction, pulmonory based home exercises, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Neurocognitive Dysfunction'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,928 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by INDIV in EARLY_PHASE1 at Boston that involved Hand Injuries and Gelfoam. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Hand Injuries'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,929 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Neurocognitive Dysfunction in PHASE4 funded by NETWORK, involving Placebo to SHP-141C. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Neurocognitive Dysfunction'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,930 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Intervertebral Disc Disorder Lumbar With Radiculopathy in PHASE4 funded by AMBIG, involving Mayo Clinic Foregut Surgery Report Card Questionnaire. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Intervertebral Disc Disorder Lumbar With Radiculopathy'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Mayo Clinic Foregut Surgery Report Card Questionnaire'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,931 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies supported by NSABP Foundation Inc that involved Neurocognitive Dysfunction and BLOOD SAMPLE in Los Angeles. Include collaborators and outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Neurocognitive Dysfunction'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BLOOD SAMPLE'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,932 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies funded by INDIV in PHASE2|PHASE3 at Los Angeles involving Chronic Antibody-mediated Transplant Rejection and Recombinant new coronavirus vaccine (CHO cell) low-dose group. Include details of outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,933 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by NSABP Foundation Inc in Chicago involving Post Cardiac Surgery and Placebo to SHP-141C. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,934 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by INDIV in PHASE3 were conducted at Boston and involved Chronic Antibody-mediated Transplant Rejection as well as Plasma? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Plasma'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,935 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies conducted by Novartis involving Bleeding Cardiac Surgery Patients and TQ-A3334 in Los Angeles. Who collaborated, and what were the outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Novartis'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Bleeding Cardiac Surgery Patients'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,936 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | What studies were conducted by Quadras Scientific Solutions in New York and involved Chronic Antibody-mediated Transplant Rejection as well as Combination therapy (S81694 + paclitaxel) phase I? What were the primary and secondary outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,937 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies conducted by Vancouver Prostate Centre involving Human Flu and Gelfoam in Helsingborg, Sweden. Who collaborated, and what were the outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,938 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by UNKNOWN in PHASE3 were conducted at Chicago and involved Ischemic Heart Disease (IHD) as well as Placebo to SHP-141C? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ischemic Heart Disease (IHD)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,939 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Laryngeal Dystonia in PHASE1 funded by OTHER, involving Nalmefene (Selincro®) 18 mg tablet. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,940 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Pulmonary Tuberculoses in PHASE3 funded by NIH, involving Gelfoam. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,941 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies supported by IHF GmbH - Institut für Herzinfarktforschung in Kristianstad, Sweden that investigated Pulmonary Tuberculoses and diet and exercise. Include details of primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'IHF GmbH - Institut für Herzinfarktforschung'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,942 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE3 funded by UNKNOWN at Chicago involving Human Flu and pulmonory based home exercises. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,943 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by OTHER in EARLY_PHASE1 were conducted at New York and involved Recurrent Hypopharyngeal Squamous Cell Carcinoma as well as Weight loss? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Weight loss'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,944 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by FED in PHASE3 at Lund, Sweden that involved Ischemic Heart Disease (IHD) and diet and exercise. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ischemic Heart Disease (IHD)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,945 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by NETWORK in PHASE3 were conducted at Chicago and involved Bleeding Cardiac Surgery Patients as well as Gelfoam? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Bleeding Cardiac Surgery Patients'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,946 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies supported by NSABP Foundation Inc in Hangzhou, Zhejiang, China that investigated Leukemia Relapse and TQ-A3334. Include details of primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Leukemia Relapse'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,947 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies sponsored by Quadras Scientific Solutions in Chicago that studied Pulmonary Tuberculoses and pulmonory based home exercises. Include primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,948 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by AMBIG in EARLY_PHASE1 at Helsingborg, Sweden. Include Bleeding Cardiac Surgery Patients, Nalmefene (Selincro®) 18 mg tablet, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Bleeding Cardiac Surgery Patients'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,949 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | What studies were conducted by IHF GmbH - Institut für Herzinfarktforschung in Kristianstad, Sweden and involved Ventricular Ectopic Beat(S) as well as Amivantamab (to be determined)? What were the primary and secondary outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'IHF GmbH - Institut für Herzinfarktforschung'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Amivantamab (to be determined)'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,950 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by OTHER in PHASE2|PHASE3 at Lund, Sweden. Include Thalassemia Intermedia, delandistrogene moxeparvovec, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,951 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE2|PHASE3 funded by AMBIG at Lund, Sweden involving Chronic Antibody-mediated Transplant Rejection and TQ-A3334. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,952 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by OTHER in PHASE3 at Boston. Include Leukemia Relapse, pulmonory based home exercises, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Leukemia Relapse'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,953 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Laryngeal Dystonia in PHASE1|PHASE2 funded by OTHER, involving diet and exercise. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,954 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Chronic Antibody-mediated Transplant Rejection in PHASE2 funded by NETWORK, involving Active MBM. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,955 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | What studies were conducted by Vancouver Prostate Centre in Kristianstad, Sweden and involved Chorea Associated With Huntington Disease as well as Amivantamab (to be determined)? What were the primary and secondary outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chorea Associated With Huntington Disease'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Amivantamab (to be determined)'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,956 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Quadras Scientific Solutions in Kristianstad, Sweden involving Hand Injuries and Gelfoam. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Hand Injuries'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,957 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by NETWORK in PHASE1|PHASE2 at Hangzhou, Zhejiang, China. Include Hand Injuries, Recombinant new coronavirus vaccine (CHO cell) low-dose group, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Hand Injuries'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,958 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by NETWORK in EARLY_PHASE1 were conducted at Boston and involved Laryngeal Dystonia as well as Recombinant new coronavirus vaccine (CHO cell) low-dose group? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,959 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Recurrent Hypopharyngeal Squamous Cell Carcinoma in PHASE3 funded by AMBIG, involving Recombinant new coronavirus vaccine (CHO cell) low-dose group. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,960 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies funded by AMBIG in PHASE2 at Lund, Sweden involving Bleeding Cardiac Surgery Patients and pulmonory based home exercises. Include details of outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Bleeding Cardiac Surgery Patients'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,961 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by AMBIG in PHASE2|PHASE3 at Boston that involved Chorea Associated With Huntington Disease and relaxation response- meditation. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chorea Associated With Huntington Disease'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,962 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Laryngeal Dystonia in PHASE1 funded by UNKNOWN, involving Combination therapy (S81694 + paclitaxel) phase I. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,963 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies conducted by J&J involving Leukemia Relapse and Nalmefene (Selincro®) 18 mg tablet in Hangzhou, Zhejiang, China. Who collaborated, and what were the outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'J&J'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Leukemia Relapse'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,964 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE2 funded by NIH at Los Angeles involving Laryngeal Dystonia and relaxation response- meditation. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,965 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies funded by AMBIG in PHASE4 at Helsingborg, Sweden involving Thalassemia Intermedia and delandistrogene moxeparvovec. Include details of outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,966 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by NIH in PHASE4 at Boston. Include Laryngeal Dystonia, BDP HFA Nasal Aerosol, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,967 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by UNKNOWN in PHASE2 at Hangzhou, Zhejiang, China that involved Ventricular Ectopic Beat(S) and relaxation response- meditation. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,968 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies supported by IHF GmbH - Institut für Herzinfarktforschung in Helsingborg, Sweden that investigated Thalassemia Intermedia and Amivantamab (to be determined). Include details of primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'IHF GmbH - Institut für Herzinfarktforschung'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Amivantamab (to be determined)'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,969 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE3 funded by INDIV at Chicago involving Post Cardiac Surgery and Plasma. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Plasma'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,970 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies funded by NIH in PHASE2 at San Francisco involving Post Cardiac Surgery and Combination therapy (S81694 + paclitaxel) phase I. Include details of outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,971 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Quadras Scientific Solutions in Lund, Sweden involving Refractory Pulmonary Edema and Active MBM. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Refractory Pulmonary Edema'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,972 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Peter Rossing in New York involving Thalassemia Intermedia and BDP HFA Nasal Aerosol. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Peter Rossing'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,973 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by OTHER_GOV in PHASE2|PHASE3 at Boston. Include Chronic Antibody-mediated Transplant Rejection, Gelfoam, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER_GOV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,974 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by INDIV in PHASE3 at Los Angeles. Include Pulmonary Tuberculoses, delandistrogene moxeparvovec, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,975 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies supported by Novartis in San Francisco that investigated Ischemic Heart Disease (IHD) and EHR clinical decision support nudges. Include details of primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Novartis'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ischemic Heart Disease (IHD)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'EHR clinical decision support nudges'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,976 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Post Cardiac Surgery in PHASE3 funded by NIH, involving Nalmefene (Selincro®) 18 mg tablet. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,977 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Leukemia Relapse in PHASE2|PHASE3 funded by NIH, involving Active MBM. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Leukemia Relapse'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,978 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies funded by OTHER_GOV in PHASE2 at Hangzhou, Zhejiang, China involving Ventricular Ectopic Beat(S) and diet and exercise. Include details of outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER_GOV'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,979 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by AMBIG in EARLY_PHASE1 at Hangzhou, Zhejiang, China. Include Ketamine Treatment, Active MBM, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ketamine Treatment'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,980 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | What studies were conducted by Vancouver Prostate Centre in New York and involved Human Flu as well as pulmonory based home exercises? What were the primary and secondary outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,981 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies funded by INDUSTRY in PHASE1 at Kristianstad, Sweden involving Human Flu and pulmonory based home exercises. Include details of outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,982 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies sponsored by Vancouver Prostate Centre in Helsingborg, Sweden that studied Refractory Pulmonary Edema and Active MBM. Include primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Refractory Pulmonary Edema'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,983 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Recurrent Hypopharyngeal Squamous Cell Carcinoma in PHASE4 funded by NIH, involving EHR clinical decision support nudges. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'EHR clinical decision support nudges'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,984 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Identify studies with Chronic Antibody-mediated Transplant Rejection in PHASE3 funded by UNKNOWN, involving Combination therapy (S81694 + paclitaxel) phase I. What were the primary and secondary outcomes, and who collaborated and sponsored them? | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,985 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by INDIV in PHASE1|PHASE2 at Helsingborg, Sweden that involved Laryngeal Dystonia and Active MBM. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,986 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies sponsored by Novartis in San Francisco that studied Post Cardiac Surgery and Active MBM. Include primary and secondary outcomes. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Novartis'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,987 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by FED in EARLY_PHASE1 were conducted at Boston and involved Human Flu as well as Guided bone regeneration? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Guided bone regeneration'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,988 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Which studies funded by INDUSTRY in PHASE3 were conducted at Chicago and involved Laryngeal Dystonia as well as Active MBM? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators? | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,989 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by INDUSTRY in PHASE2|PHASE3 at Lund, Sweden that involved Kidney Carcinoma and delandistrogene moxeparvovec. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Kidney Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,990 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by NIH in PHASE1 at Lund, Sweden. Include Recurrent Hypopharyngeal Squamous Cell Carcinoma, pulmonory based home exercises, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,991 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE2 funded by OTHER at Boston involving Recurrent Hypopharyngeal Squamous Cell Carcinoma and relaxation response- meditation. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,992 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | What studies were conducted by J&J in Los Angeles and involved Recurrent Hypopharyngeal Squamous Cell Carcinoma as well as Gelfoam? What were the primary and secondary outcomes? | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'J&J'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome |
99,993 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by FED in PHASE2 at Helsingborg, Sweden that involved Human Flu and delandistrogene moxeparvovec. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,994 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Novartis in Los Angeles involving Thalassemia Intermedia and delandistrogene moxeparvovec. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Novartis'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,995 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Find studies supported by NETWORK in PHASE2|PHASE3 at Boston. Include Chronic Antibody-mediated Transplant Rejection, Plasma, primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Plasma'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,996 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies funded by INDUSTRY in PHASE3 at Helsingborg, Sweden that involved Chorea Associated With Huntington Disease and BDP HFA Nasal Aerosol. Include primary and secondary outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chorea Associated With Huntington Disease'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,997 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | Show studies conducted by Pfizer in Lund, Sweden involving Laryngeal Dystonia and BLOOD SAMPLE. Include collaborators and outcome details. | MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Pfizer'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BLOOD SAMPLE'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name |
99,998 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE3 funded by NETWORK at Kristianstad, Sweden involving Neurocognitive Dysfunction and Placebo to SHP-141C. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Neurocognitive Dysfunction'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
99,999 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE4 funded by OTHER at Hangzhou, Zhejiang, China involving Alpha1-antitrypsin Deficiency and Weight loss. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Alpha1-antitrypsin Deficiency'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Weight loss'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |
100,000 | clinical_trials | Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType) | List studies in PHASE1|PHASE2 funded by INDUSTRY at Lund, Sweden involving Recurrent Hypopharyngeal Squamous Cell Carcinoma and Combination therapy (S81694 + paclitaxel) phase I. Include outcomes, sponsors, and collaborators. | MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name |